BMO Capital Markets initiated coverage on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report released on Tuesday, MarketBeat reports. The firm issued an outperform rating and a $22.00 price target on the stock. MGX has been the topic of a number of other reports. Wells Fargo & Company initiated coverage on shares […]